An ophthalmologist pulls the recall report on a Tuesday morning. Three hundred patients overdue. The report is sorted by how late they are, not by how much trouble they are in. Somewhere on it is a wet AMD patient who stopped coming after their fourth anti-VEGF injection. Nothing on the report makes that patient stand out from the routine annual two rows above them.
And here is the part that makes it worse. Even if you could pick that patient out, nobody on your team has the time to pull three hundred charts and find the handful who are mid-treatment and quietly deteriorating. When one academic group went looking for their glaucoma patients who had been lost to follow-up, 90% of them already had an active but overdue scheduling order sitting in the system (Ophthalmology Science, 2022). The work wasn't unknown. It was unworked. The front desk is handling check-ins, insurance, referrals, and a phone that doesn't stop. The overdue report is a background task that never becomes a foreground task. It just grows.
So there are two failures stacked on top of each other. The report treats clinical danger and ordinary lateness as the same kind of overdue, and the team doesn't have the time to go chart by chart and tell them apart.
The EHR Tracks Time, Not Trajectory
The major ophthalmology EHRs, ModMed EMA and Nextech among them, are good at what they were built to do. You can set recall intervals by visit type, so a glaucoma patient comes up on a shorter clock than a routine annual. Some will automate diabetic monitoring recalls and track glaucoma progression across visits. None of that is the problem.
Here is the problem with what a recall interval actually measures. A recall clock tracks one thing: time since the last visit. For a patient on a steady cadence, like a routine annual, that is exactly the right number. But an active treatment series is governed by something the clock never sees: time since the last dose. For an injection patient, that second number is the only one that matters. The interval between anti-VEGF doses is the thing holding their vision in place. Let it stretch too far and the damage starts, whether or not they happen to be due for a visit. When that patient no-shows the next injection, the system logs a missed appointment, not a treatment series coming apart. They surface, if they surface at all, as one more overdue name to be worked in whatever order the staff gets to.
"An active treatment series is governed by something the clock never sees: time since the last dose."
A routine annual that slips by two months is a scheduling matter. An injection series that breaks for six months is, in the published literature, likely irreversible vision loss. The recall report doesn't carry that distinction, because it was built to track appointments, not treatment trajectories.
In This Specialty, the Gap Is Vision
Start with the scale of what's known here, because ophthalmology has better data on its own dropout problem than almost any specialty in medicine. The American Academy of Ophthalmology's IRIS Registry holds data on more than 50 million patients, contributed by roughly 70% of the practicing ophthalmologists in the country (American Academy of Ophthalmology). When a pattern shows up in that data, it isn't one clinic's bad luck. It's the specialty.
Take glaucoma. A registry analysis of 208,517 primary open-angle glaucoma patients found that 18.4% went missing from care for somewhere between one and four years (Canadian Journal of Ophthalmology, 2026). These weren't undiagnosed patients. They were in the system and being monitored, right up until they weren't. And the longer the gap ran, the more likely those patients were to show measurable structural progression by the time anyone saw them again. Glaucoma doesn't announce itself. The patient feels fine while the optic nerve quietly gives ground, and by the time vision is obviously worse, the loss is permanent.
The injection patients are the sharper version of the same story. A 2023 meta-analysis pooled 409,215 patients across 52 studies and put non-persistence with anti-VEGF therapy at roughly 30% (Systematic Reviews, 2023). Close to one in three patients, on one of the most time-sensitive treatments in all of medicine, stops showing up. And the timing is the whole game. Studies of these patients define long-term loss to follow-up as a gap of more than six months, and that's the group that loses vision it doesn't get back, even after treatment resumes (Graefe's Archive for Clinical and Experimental Ophthalmology, 2025).
That is the distance between ophthalmology and most of the specialties a recall system was designed for. A lapsed dental cleaning can be rescheduled and nothing is lost in the meantime. A lapsed glaucoma check or a missed injection is time the patient doesn't get back. The clock the EHR can't see is the same clock that decides whether the patient keeps their sight.
"The clock the EHR can't see is the same clock that decides whether the patient keeps their sight."
Care Recovery Reads Care State, Not Calendar State
The patient who walked away from an injection series after dose four doesn't need to be convinced that their eyes matter. They were showing up. Something got in the way. Maybe a ride fell through or a copay landed at the wrong moment. Maybe the reminder didn't register as urgent because it looked exactly like every other "you're due" text. What they need is to be found and pulled back before the gap turns into vision they don't get to recover.
Care Recovery™ is the layer that identifies patients whose care sequence is incomplete and routes them back to the clinic. It sits on top of the EHR you already run. It doesn't replace recall. It reads what recall can't see: where a patient actually is in their treatment, not just how long it has been since they were last in the chair.
It never gets ahead of you, either. Care Recovery surfaces the patient and what looks incomplete in their care. What happens next stays your call, down to whether the patient hears from the practice at all. The clinical judgment is yours. The system only makes sure the patient who needs it is in front of you to begin with.
So the glaucoma patient who was diagnosed and put on drops, then stopped coming in for pressure checks, gets surfaced as what they are, a monitored patient who went dark, instead of a name halfway down an overdue report. The diabetic patient who was being watched for retinopathy and quietly fell off monitoring gets caught before silent progression turns into an emergency. The injection patient gets flagged on a clock that matches their treatment, not a calendar interval that treats them like a routine annual.
Or the cataract consult that never turned into a surgery date. The patient came in, met criteria, heard the plan, and walked out without booking. Maybe the cost gave them pause. Maybe they decided they would deal with it once it got worse. The chart shows a consult and no surgery, and to the EHR that is a closed encounter. To the practice it is a clinically indicated case that never made it onto the schedule. Care Recovery sees the gap between the consult and the booking and surfaces it while it is still recoverable.
The outreach isn't an overdue blast. It's a message written for that one patient and the treatment they were in the middle of, in the kind of language the front desk would use if they had the time to call. It reads like someone at the practice noticed they hadn't been back and wanted to check in. Not "you're due." Definitely not "you're due for" followed by a procedure code. A real check-in about the care they already started.
The List Is Already in Your Chart
I have been the patient on the other end of this. An eye doctor told me to come back for a follow-up. I forgot. Nobody ever checked in. By the time I remembered, three years had gone by. Not out of negligence on their part. It is the same thing my mom described after forty years as a dental and periodontal assistant: the patients in front of you need everything you have, and there is nothing left over to chase the ones who slipped away. The staff isn't the failure point. The time is. You didn't choose this specialty to watch a patient drift toward damage you could have stopped, but intent doesn't pull charts.
The patients who need to come back are already in your system. They were diagnosed. They started treatment. Some are sitting on an overdue report right now at the same priority as a routine annual, while their condition moves in a direction that doesn't reverse. Every one of them is an injection series that could resume or a case that could finally get on the surgical schedule, sitting in data you already own. The hard part, getting them in the door the first time, is already done. What no one has time to do is find them again.
If you want to see how many of those patients are sitting in your data, run the scan. The names are already there.